SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001558370-16-004804
Filing Date
2016-04-25
Accepted
2016-04-25 16:06:00
Documents
3
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A acrs-20151231x10ka.htm 10-K/A 554085
2 EX-31.1 acrs-20151231ex31176343b.htm EX-31.1 8108
3 EX-31.2 acrs-20151231ex3124c04f9.htm EX-31.2 8080
  Complete submission text file 0001558370-16-004804.txt   571275
Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37581 | Film No.: 161589091
SIC: 2834 Pharmaceutical Preparations